
Cell-free DNA programme could ‘empower’ therapeutics to market
A newly accessible cell-free DNA programme could “empower” therapeutics to market, the CEO of Ribbon Bio has said. Jodi Barrientos, CEO of the synthetic biology company, was speaking at the ‘Engineering Biology: DNA and Beyond’ conference in Vienna, Austria, which took place on the 5 and 6 March. At the… Read More



